BioXcel Therapeutics, Inc.
BTAIQ- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001720893
No open-market purchases or sales by BioXcel Therapeutics, Inc. insiders were filed in the last 90 days; 47 institutions reported holding it in 13F filings for Q2 2026, worth $8.69M in total; Oaktree Capital is the only superinvestor holding it.
13F holders, Q2 2025
Institutional positions in BioXcel Therapeutics, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 35
- +4 vs. Q1 2025
- Shares held
- 618.1K
- +239.1K (+63.1%) vs. Q1 2025
- Total value
- $1.09M
- +$320.9K (+41.7%) vs. Q1 2025
- New holders
- 9
- 6 more added
- Sold out
- 5
- 8 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BTAIQ on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 47 | $8.69M |
| Q1 2026 | 40 | $7.28M |
| Q4 2025 | 41 | $5.66M |
| Q3 2025 | 35 | $6.05M |
| Q2 2025 | 35 | $1.09M |
| Q1 2025 | 31 | $769.7K |
| Q4 2024 | 49 | $3.22M |
| Q3 2024 | 50 | $1.89M |
| Q2 2024 | 74 | $12.5M |
| Q1 2024 | 74 | $26.1M |
| Q4 2023 | 73 | $27.6M |
| Q3 2023 | 86 | $25.8M |
| Q2 2023 | 88 | $117.8M |
| Q1 2023 | 97 | $325.0M |
| Q4 2022 | 84 | $288.9M |
| Q3 2022 | 85 | $140.3M |
| Q2 2022 | 94 | $167.4M |
| Q1 2022 | 96 | $273.9M |
| Q4 2021 | 93 | $283.1M |
| Q3 2021 | 104 | $388.3M |
| Q2 2021 | 109 | $378.6M |
| Q1 2021 | 118 | $475.2M |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding BioXcel Therapeutics, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Federation des caisses Desjardins du Quebec | 1 | $2 | 0.00% | −2−66.7% | Reduced |
| US Bancorp | 1 | $2 | 0.00% | 00.0% | Unchanged |
| Mount Yale Investment Advisors, LLC | 1 | $2 | 0.00% | +1 | New |
| Danske Bank A/S | 3 | $5 | 0.00% | 00.0% | Unchanged |
| National Bank of Canada | 6 | $11 | 0.00% | −21−77.8% | Reduced |
| Barclays PLC | 8 | $14 | 0.00% | −1,902−99.6% | Reduced |
| Northwestern Mutual Wealth Management Co | 21 | $38 | 0.00% | 00.0% | Unchanged |
| GWM Advisors LLC | 31 | $57 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 44 | $80 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 45 | $81 | 0.00% | −71−61.2% | Reduced |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 103 | $186 | 0.00% | 00.0% | Unchanged |
| Parkside Financial Bank & Trust | 112 | $203 | 0.00% | 00.0% | Unchanged |
| Raymond James Financial Inc | 125 | $226 | 0.00% | +125 | New |
| Washington Trust Advisors, Inc. | 160 | $290 | 0.00% | 00.0% | Unchanged |
| AllSquare Wealth Management LLC | 175 | $317 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 879 | $1.59K | 0.00% | +28+3.3% | Added |
| Group One Trading, L.P. | 1,273 | $2.30K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,370 | $2.48K | 0.00% | +1,218+801.3% | Added |
| Bank of America Corp | 1,547 | $2.80K | 0.00% | +28+1.8% | Added |
| Morgan Stanley | 1,580 | $2.86K | 0.00% | −186−10.5% | Reduced |
| Advisor Group Holdings, Inc. | 5,053 | $9.14K | 0.00% | +3,169+168.2% | Added |
| Citadel Advisors LLC | 11,378 | $20.6K | 0.00% | +11,378 | New |
| Wells Fargo & Company | 16,919 | $30.6K | 0.00% | +4,626+37.6% | Added |
| BlackRock, Inc. | 17,778 | $32.2K | 0.00% | −5,463−23.5% | Reduced |
| Vanguard Group Inc | 18,824 | $34.1K | 0.00% | 00.0% | Unchanged |
| Beacon Pointe Advisors, LLC | 18,845 | $34.1K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 23,424 | $42.4K | 0.00% | +23,424 | New |
| HighTower Advisors, LLC | 24,600 | $44.5K | 0.00% | +24,600 | New |
| Jones Financial Companies LLLP | 26,000 | $46.0K | 0.00% | +26,000 | New |
| Geode Capital Management, LLC | 28,182 | $51.0K | 0.00% | +6,120+27.7% | Added |
| UBS Group AG | 39,882 | $72.2K | 0.00% | −61,896−60.8% | Reduced |
| Oaktree Fund Advisors, LLC | 42,913 | $77.7K | 0.13% | +42,913 | New |
| Murchinson Ltd. | 80,618 | $145.9K | 0.08% | −55,458−40.8% | Reduced |
| Oaktree Capital Management LPSuperinvestorOaktree Capital | 241,188 | $436.6K | 0.01% | +241,188 | New |
| Diversify Wealth Management, LLC | 15,000 | – | – | +15,000 | New |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −24,794−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −10,666−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −237−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −11−100.0% | Sold out |
| Farther Finance Advisors, LLC | 0 | $0 | 0.00% | −5−100.0% | Sold out |